Omeros | OMER - Cost Of Sales


Omeros reported $33.16M in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
Adma Biologics USD 50.4M 8.24M Dec/2025
Alnylam Pharmaceuticals USD 211.12M 56.6M Mar/2026
BioMarin Pharmaceutical USD 199.48M 37.93M Mar/2026
Cytokinetics USD 160K 104.24M Mar/2026
Gilead Sciences USD 1.44B 174M Mar/2026
Heron Therapeutics USD 11.12M 795K Dec/2025
Insmed USD 49.5M 3.34M Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
MacroGenics USD 10.12M 34.18M Dec/2025
Omeros USD 33.16M 18.52M Jun/2024
Pacira USD 50.74M 3.89M Mar/2026
Pfizer USD 4.59B 1.7B Mar/2026
Rockwell Medical USD 21.28M 1.67M Jun/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sarepta Therapeutics USD 109.46M 289.93M Mar/2026
United Therapeutics USD 133.4M 341.3M Mar/2026
Vertex Pharmaceuticals USD 392.8M 73.2M Mar/2026
Xoma 116K 112.7K Jun/2024